Seeking Alpha

Animalspirit12

Animalspirit12
Send Message
View as an RSS Feed
View Animalspirit12's Comments BY TICKER:
Latest  |  Highest rated
  • MannKind Finally Catches A Break [View article]
    Try to keep your facts straight
    May 19, 2015. 11:29 AM | 2 Likes Like |Link to Comment
  • MannKind Finally Catches A Break [View article]
    BearCrusher,
    Your arguments are spurious.
    If a patient is diabetic, and needs a treatment, and a test is needed assess the patient prior to or during treatment, that treatment is considered medically necessary. Medically necessity is anything a physician deems necessary for a patients health. For reimbursement, all that is necessary is to provide the documentation to the third party payers. Yes, it is at times an administrative burden and this is part of the reason physicians are often reluctant to prescribe or order anything that is relatively new. As many others have posted, the actual process of obtaining an FEV1 is trivial and can be done in minutes in an office by a nurse or physician assistant.
    Nor do you need a diagnosis of trypanophobia to dislike needles, or specialty certification in psychiatry to identify anxiety or other phobias in a patient.
    You are certainly entitled to your opinions and your motivation and persistence is impressive but you should try to get your facts straight.
    May 19, 2015. 11:28 AM | 3 Likes Like |Link to Comment
  • Healthcare ratings roundup - upgrades/downgrades [View news story]
    That should be very interesting.
    (Serious, no sarcasm or humor)
    May 16, 2015. 10:26 AM | Likes Like |Link to Comment
  • Healthcare ratings roundup - upgrades/downgrades [View news story]
    I'm sorry. I was enjoying this little thread away from the other articles and thought you were too. Don't share my sense of humor in mocking the absurd arguments against Afreeza? That's OK. The arguments against are even more outrageous when Afreeza is compared to the other treatments which the FDA has approved for treatment of type II DM. It is only a matter of time before Sanofi conducts the scientific studies making the direct comparisons.
    Good luck to all the shorts, bears and other skeptics waiting to cover or invest at that time. I can't take them seriously and plan on having some very big laughs then.
    Long MNKD :)
    May 16, 2015. 10:12 AM | 2 Likes Like |Link to Comment
  • Healthcare ratings roundup - upgrades/downgrades [View news story]
    Oh that's much too new and controversial Dr. Chow. such a thing should not even be suggested by non-endocrinologists like us despite the fact that we encounter patients with poorly managed diabetes and its complications on a daily basis. We MUST wait until the endocrinologists have data that actually shows taking the inhaled insulin is superior to taking oral drugs which work poorly and have dangerous side effects and drug interactions which are the standard of care. Besides don't you know that Sanofi is going to pull the plug on that drug? That's according to financial experts on the street who of course rarely wrong but never in doubt :)
    May 15, 2015. 06:12 PM | 4 Likes Like |Link to Comment
  • Healthcare ratings roundup - upgrades/downgrades [View news story]
    If only there were some way to administer insulin without injection.
    Maybe a pill or something?
    Sigh.
    Well I am sure big pharma is working on that. And when it does get approved I am sure the FDA will make sure it is safe before they approve it.

    May 15, 2015. 03:58 PM | 5 Likes Like |Link to Comment
  • Healthcare ratings roundup - upgrades/downgrades [View news story]
    Of course, when other options have tried and failed there's always insulin, the life-saving discovery of Banting and Best!

    Yes, yes, I know what all of you are saying. With the need for multiple daily injections and the risk of hypoglycemia insulin therapy, even as effective as it is, will remain the therapy of last resort for type IIs. Especially given the many other innovative and beneficial treatment options for type II DM.
    May 15, 2015. 03:53 PM | 1 Like Like |Link to Comment
  • Healthcare ratings roundup - upgrades/downgrades [View news story]
    Oh and how could I forget, good old Avandia. So glad that's still available for clinical use. It was such a setback when they stopped allowing patients to take it without a physician's prescription, limiting the number of patients with diabetes that could get access to its' benefits.
    May 15, 2015. 03:33 PM | 1 Like Like |Link to Comment
  • Healthcare ratings roundup - upgrades/downgrades [View news story]
    Good old diet changes weight loss and exercise!

    Oh yeah and metformin.
    May 15, 2015. 03:30 PM | 1 Like Like |Link to Comment
  • Healthcare ratings roundup - upgrades/downgrades [View news story]
    Well at least now that I and the public have been notified. If I encounter signs of ketoacidosis in my patients who are on these SGLT2 inhibitors, I will be able to recognize the cause and recommend they discontinue these innovative new medications and return to the standard, tried and true therapies.
    May 15, 2015. 03:29 PM | 3 Likes Like |Link to Comment
  • Healthcare ratings roundup - upgrades/downgrades [View news story]
    feel so reassured that the FDA is on the case, keeping healthcare professionals and patients informed about these medications.

    http://1.usa.gov/1PoqffI

    As they mention in their safety communication, diabetes when untreated can lead to serious problems including blindness, nerve and kidney damage, and heart disease.

    I guess it is important to weigh the benefits of lower blood sugar against the potential side effects of a medication used to treat diabetes.
    May 15, 2015. 03:23 PM | 3 Likes Like |Link to Comment
  • Healthcare ratings roundup - upgrades/downgrades [View news story]
    What a shocker! A new class of drug for type II diabetics with no long term safety record is suddenly found to have toxic side effects. I'm not sure but it seems like I may have heard this story before somewhere this story before? Well I
    May 15, 2015. 03:01 PM | 4 Likes Like |Link to Comment
  • Healthcare ratings roundup - upgrades/downgrades [View news story]
    Interesting to see if there is a decline in short interest versus institutions building positions.
    May 15, 2015. 01:47 PM | 1 Like Like |Link to Comment
  • Early Adopters Embrace Afrezza, As New Inhaled Insulin Enters Market [View article]
    Robert,

    Al Mann has published data on the use of Afrezza by Type 2 diabetics. There was a wide margin of safety with various doses and carbohydrate loads.

    Sanofi has the ball now and you can bet they have already designed a study to demonstrate the benefits of Afreeza for type 2 patients in both the short and long term.
    Mar 25, 2015. 05:22 AM | 1 Like Like |Link to Comment
  • Jefferies lowers MannKind price target 10% due to longer ramp [View news story]
    http://bit.ly/1DU7x9P
    Mar 24, 2015. 12:24 PM | 4 Likes Like |Link to Comment
COMMENTS STATS
49 Comments
101 Likes